Rousselot, Darling Ingredients' health brand, and the global leader of collagen-based solutions1, announces that the European Patent Office (EPO) has granted the company's patent...
Kazia Therapeutics Limited , an oncology-focused drug development company, is pleased to announce positive final data from a phase II clinical study of paxalisib...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced it will present data from six company-sponsored studies in support of their respiratory syncytial virus...
Synapse PDI, the nation's leading and largest SNF-focused DME Rental Benefit Manager (DBM), is thrilled to announce its latest integration with PointClickCare, the leading...
Johnson & Johnson (the Company) announced preliminary results from an independent study, including a subset of participants from the Janssen-sponsored COV2008 study, conducted by...
